लोड हो रहा है...

The Effects of the L / N‐Type Calcium Channel Blocker (Cilnidipine) on Sympathetic Hyperactive Morning Hypertension: Results From ACHIEVE‐ONE

The Ambulatory Blood Pressure Control and Home Blood Pressure (Morning and Evening) Lowering By N‐Channel Blocker Cilnidipine (ACHIEVE‐ONE) trial is a large‐scale clinical study on blood pressure (BP) and pulse rate (PR) in the real world with use of cilnidipine, a unique L/N‐type Ca channel blocker...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Hypertens (Greenwich)
मुख्य लेखकों: Kario, Kazuomi, Ando, Shin‐ichi, Kido, Hidenori, Nariyama, Jin, Takiuchi, Shin, Yagi, Tetsuo, Shimizu, Toshiki, Eguchi, Kazuo, Ohno, Minoru, Kinoshita, Osamu, Yamada, Takahisa
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Blackwell Publishing Ltd 2012
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034443/
https://ncbi.nlm.nih.gov/pubmed/23339732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12042
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!